Tag: bostwick

Quick Search


PCRI News – The Finasteride Controversy

Mon 16 Feb 2004

The Finasteride Controversy Monday, February 16, 2004 Last summer, a team of 16 researchers reported on the seven-year Prostate Cancer Prevention Trial study that followed almost 19,000 men. The article, entitled “The Influence of Finasteride on the Development of Prostate Cancer”, was published in the July 17, 2003 issue of The New England Journal ofRead More ›

Does Finasteride Alter the Pathology of the Prostate and Cancer Grading?

Sun 1 Feb 2004

By David G. Bostwick M.D., M.B.A., Bostwick Laboratories, Richmond, Virginia Reprinted from PCRI Insights February 2004 v7.1 Introduction One of the most important and popular forms of treatment for prostate cancer, androgen deprivation therapy (ADT), has been in use for more than 50 years. In the past two decades, new forms of androgen deprivation haveRead More ›